Entering text into the input field will update the search result below

Altimmune Q1 loss soars 282% as expenses rise dramatically; shares up ~3%

May 17, 2021 11:54 AM ETAltimmune, Inc. (ALT) StockALTBy: Jonathan Block, SA News Editor
  • Altimmune's (NASDAQ:ALT) Q1 net loss rose 282% year-over-year to $14.9M ($0.38 per share) as both R&D, and general and administrative expenses rose dramatically.
  • For the quarter, Altimmune beat on EPS but missed on revenue, which fell nearly 64% year-over-year.
  • R&D

Recommended For You

More Trending News

About ALT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ALT--
Altimmune, Inc.